Clinical value of control nutritional status for the prognostic evaluation of cervical cancer patients with FIGO ⅠB~ ⅡA stage

Jiang Li,Qian Hua,Yuan Donglan, Zhao Yinling, Bu Xinhua

Electronic Journal of Metabolism and Nutrition of Cancer ›› 2022, Vol. 9 ›› Issue (5) : 665-671.

PDF(1722 KB)
PDF(1722 KB)
Electronic Journal of Metabolism and Nutrition of Cancer ›› 2022, Vol. 9 ›› Issue (5) : 665-671.

Clinical value of control nutritional status for the prognostic evaluation of cervical cancer patients with FIGO ⅠB~ ⅡA stage

  • Jiang Li ,Qian Hua ,Yuan Donglan, Zhao Yinling, Bu Xinhua
Author information +
History +

Abstract

Objective To explore the clinical value of controlling nutritional status CONUT in the prognostic evaluation of cervical cancer patients. Method A total of 122 FIGO ⅠB~ⅡA stage patients who received surgical resection for cervical cancer in Taizhou People's Hospital from January 2016 to December 2018 were included in this study. All patients were divided into CONUT <3 points and CONUT ≥3 according to the CONUT score. The distributions of baseline characteristics between the two groups were compared by χ 2 test or Fisher's exact test. The survival curves were plotted and the 5-year overall survival OS rates of patients in CONUT <3 points and CONUT ≥3 points group were calculated using Kaplan-Meier curve. Univariate and multivariate Cox regression analysis was conducted to identify the independent prognostic factors for cervical cancer patients. Result The frequency of pelvic lymph node metastasis 42. 9% vs 23. 7% χ 2 = 4. 758 P= 0. 029 and the proportion of FIGO ⅡA stage 64. 3% vs 42. 5% χ 2 = 5. 229 P= 0. 022 were significantly higher in the CONUT≥3 points group than in the CONUT <3 points group. Kaplan-Meier curve showed that the 5- year OS rates of patients in the CONUT≥3 points and CONUT <3 points group were 63. 4% and 86. 6% respectively χ 2 = 11. 409 P= 0. 001 . Subgroup analysis further confirmed that CONUT≥3 points was a significant predictor of poor OS for cervical cancer patients irrespective of FIGO stage FIGO ⅠB stage 65. 8% vs 95. 5% χ 2 = 7. 902 P= 0. 005 FIGO ⅡA stage 62. 7% vs 76. 1% χ2 = 4. 206 P= 0. 043 . In addition the univariate and multivariate Cox analysis revealed that preoperative CONUT HR = 3. 542 95%CI = 1. 529 - 8. 207 P = 0. 008 tumor size HR = 2. 668 95% CI = 1. 158 - 6. 149 P = 0. 021 and pelvic lymph node metastasis HR= 3. 542 95%CI = 1. 529-8. 207 P = 0. 003 were independent prognostic factors for cervical cancer patients. Conclusion CONUT was an effective tool of prognostic evaluation and it might have an important clinical value for cervical cancer patients with FIGO ⅠB~ⅡA stage.

Cite this article

Download Citations
Jiang Li,Qian Hua,Yuan Donglan, Zhao Yinling, Bu Xinhua. Clinical value of control nutritional status for the prognostic evaluation of cervical cancer patients with FIGO ⅠB~ ⅡA stage[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2022, 9(5): 665-671
PDF(1722 KB)

Accesses

Citation

Detail

Sections
Recommended

/